Trial
NCT02885012
Crossover Study From Macitentan or Bosentan Over to Ambrisentan
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical University of South Carolina
Collaborators
Ochsner Health System
Condition
Pulmonary Arterial Hypertension
Intervention
Ambrisentan
Why stopped
Study ending due to lack of enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-08